Ultralife Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ultralife Corporation - ULBI
Kahn Swick & Foti, LLC is investigating the adequacy of the price and process in Ultralife Corporation’s proposed sale to EnerSys. Under the proposed terms, Ultralife shareholders would receive $16.00 in cash per share.
Why it matters — The investigation concerns the consideration and process for ULBI’s proposed sale.